LuxemburgNews
19/10/2021
Biotech: a stop that will not last
This year the healthcare sector, and in particular the small and mid-cap biotechnology companies,...
23/09/2021
What impact will inflation have on corporate earnings?
US inflation data for August confirmed the presence of two opposing forces, which contributed...
16/09/2021
China: opportunities within the revolution
The regulatory tension that China is facing is also affecting market prices and in particular, as...
13/08/2021
The BoLe Chronicle | August 2021
ESG with Chinese characteristics
'Now, what if yours truly tell you that the first time he...
16/06/2021
Post-COVID, new opportunities for Biotech
There are three main catalysts for the sector: the end of lockdown, the upturn in M&A activities...
10/06/2021
Pharus Sicav Best Regulated Companies distributes the third dividend
Pharus team is pleased to inform that, on June 17, 2021, the semi-annual dividend...
07/06/2021
The BoLe Chronicle | May 2021
The rise and rise of Asia, yet where are the cheerleaders
Have lost count how many years in a...
18/05/2021
Inflation: temporary or not?
The market has been hit in recent months by the rise in inflation and although it...
30/04/2021
The BoLe Chronicle | April 2021
Talking ESG with Asian Edgies
Some of you might have heard me speaking on the topic already...